Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Common Equity (2016 - 2025)

Historic Common Equity for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $332.4 million.

  • Phibro Animal Health's Common Equity rose 3466.71% to $332.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $332.4 million, marking a year-over-year increase of 3466.71%. This contributed to the annual value of $285.7 million for FY2025, which is 1131.58% up from last year.
  • As of Q4 2025, Phibro Animal Health's Common Equity stood at $332.4 million, which was up 3466.71% from $311.7 million recorded in Q3 2025.
  • Phibro Animal Health's Common Equity's 5-year high stood at $332.4 million during Q4 2025, with a 5-year trough of $215.9 million in Q1 2021.
  • Over the past 5 years, Phibro Animal Health's median Common Equity value was $266.5 million (recorded in 2022), while the average stood at $265.7 million.
  • As far as peak fluctuations go, Phibro Animal Health's Common Equity tumbled by 915.65% in 2024, and later surged by 3466.71% in 2025.
  • Over the past 5 years, Phibro Animal Health's Common Equity (Quarter) stood at $239.3 million in 2021, then grew by 12.15% to $268.4 million in 2022, then increased by 0.91% to $270.8 million in 2023, then decreased by 8.86% to $246.8 million in 2024, then skyrocketed by 34.67% to $332.4 million in 2025.
  • Its Common Equity stands at $332.4 million for Q4 2025, versus $311.7 million for Q3 2025 and $285.7 million for Q2 2025.